4-(4-(4-Bromophenyl)-5-((3-methylbenzyl)thio)-4H-1,2,4-triazol-3-yl)pyridine

Catalog No. :
ACPDVN695
CAS No. :
477330-90-8
Molecular Formula :
C21H17BrN4S
Molecular Weight :
437.37

IUPAC Name:4-(4-(4-bromophenyl)-5-((3-methylbenzyl)thio)-4H-1,2,4-triazol-3-yl)pyridine

4-(4-(4-Bromophenyl)-5-((3-methylbenzyl)thio)-4H-1,2,4-triazol-3-yl)pyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(4-(4-Bromophenyl)-5-((3-methylbenzyl)thio)-4H-1,2,4-triazol-3-yl)pyridine
IUPAC Name4-(4-(4-bromophenyl)-5-((3-methylbenzyl)thio)-4H-1,2,4-triazol-3-yl)pyridine
MDL No.MFCD03474523
Molecular FormulaC21H17BrN4S
Molecular Weight437.37
SMILESCC1=CC(CSC2=NN=C(C3=CC=NC=C3)N2C4=CC=C(Br)C=C4)=CC=C1
InChI KeyDQUZTKOAGBRTBM-UHFFFAOYSA-N
SynonymSALOR-INT L244503-1EA;4-(4-(4-BROMOPHENYL)-5-((3-METHYLBENZYL)THIO)-4H-1,2,4-TRIAZOL-3-YL)PYRIDINE;Pyridine, 4-[4-(4-bromophenyl)-5-[[(3-methylphenyl)methyl]thio]-4H-1,2,4-triazol-3-yl]-
CAS No.477330-90-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACPDVN695 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPDVN695 route product structure diagram
    ACPDVN695477330-90-8
Inquiry

2. ACPDVN695 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPDVN695 route product structure diagram
    ACPDVN695477330-90-8
Inquiry

Comments (0)